Financials
| Half-year Report | Jul. 15, 2024 |
| 2023 Annual Results | May. 30, 2024 |
| Half-year Report | Sep. 29, 2023 |
| 2022 Annual Results | Jun. 05, 2023 |
| Half-year Report | Sep. 07, 2022 |
| Final Results | May. 19, 2022 |
| Half-year Report | Sep. 13, 2021 |
Proxies
| Result of AGM | Jun. 25, 2024 |
| Notice of AGM and posting of Annual Report | May. 31, 2024 |
| Result of AGM | Jun. 29, 2023 |
| Notice of AGM and posting of Annual Report | Jun. 06, 2023 |
| Result of AGM and voting results | Jun. 27, 2022 |
| Posting of Annual Report & Accounts | May. 25, 2022 |
| Result of AGM | May. 19, 2021 |
Ownership Update
| Holding(s) in Company | Feb. 27, 2024 |
| Holding(s) in Company | Feb. 22, 2024 |
| Holding(s) in Company | Feb. 21, 2024 |
| Holding(s) in Company | Feb. 21, 2024 |
| Director/PDMR Shareholding | Dec. 07, 2022 |
| Correction: Holding(s) in Company | Dec. 01, 2022 |
| Holding(s) in Company | Jun. 24, 2022 |
Announcements
| Notice of Results and Business Update | Jul. 11, 2024 |
| Significant milestone re Thermo Fisher agreement | Jul. 01, 2024 |
| Transfer of urine samples to Thermo Fisher | Jun. 18, 2024 |
| Launch of patient-focused educational tool | May. 31, 2024 |
| New data to be presented at ATC | May. 24, 2024 |
| Verici Dx announces new research initiative | Jan. 31, 2024 |
| Publication of Circular | Jan. 26, 2024 |